ClinConnect ClinConnect Logo
Search / Trial NCT06524791

Prevalence of Faecal Bacteriophage in Patients With Digestive Symptoms

Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Jul 24, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Bacteriophages

ClinConnect Summary

This clinical trial is studying the presence of specific viruses called fecal bacteriophages in people who have digestive symptoms, such as gastroenteritis. The researchers want to find out how common these viruses are in stool samples from individuals who show signs of digestive issues. They will look at both the amount of infectious fecal phages and their genetic material in the participants' stool. Additionally, the study aims to understand if certain factors, like having a healthy immune system or being immunocompromised, affect the presence of these viruses.

To participate in this trial, individuals must be between 18 and 60 years old and experiencing gastrointestinal symptoms that require stool testing while in the hospital. Importantly, participants will need to give their consent to use their data for the study. The trial is not yet recruiting participants, so there’s no need to worry about enrolling just yet. Overall, this research could help improve our understanding of digestive problems and the role of these viruses in such conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age between 18 and 60.
  • Persons having developed gastrointestinal symptoms justifying microbiological stool testing at the time of hospitalization.
  • Person having received full information on the organization of the research and not having objected to the use of this data
  • Exclusion Criteria:
  • Persons covered by articles L. 1121-5, L. 1121-7 and L1121-8 of the French Public Health Code.
  • Pregnant or breast-feeding women,
  • Minors (not emancipated),
  • Adult subject to a legal protection measure (guardianship, curatorship, safeguard of justice),
  • Persons of full age who are unable to give their consent.
  • Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care by virtue of articles L. 3212-1 and L. 3213-1.

About Central Hospital, Nancy, France

Central Hospital, located in Nancy, France, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is committed to conducting innovative studies across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Central Hospital leverages its state-of-the-art facilities and expertise to contribute to the development of cutting-edge treatments and enhance the overall quality of care within the community and beyond.

Locations

Nancy, , France

Patients applied

0 patients applied

Trial Officials

Cédric Hartard

Principal Investigator

CHRU Nancy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported